AI assistant
N4 PHARMA PLC — Director's Dealing 2016
Aug 9, 2016
7804_dirs_2016-08-09_12f24f27-9c77-4e1b-9ae3-9d9e82e18f91.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7030G
Verona Pharma PLC
09 August 2016
Verona Pharma plc
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Dr. Jan-Anders Karlsson
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Verona Pharma plc
b)
LEI
n/a
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 0.1 pence each
GB00B06GSH43
b)
Nature of the transaction
Jan-Anders Karlsson purchased 600,000 Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 3.249 pence per Ordinary Share | 600,000 Ordinary Shares |
d)
Aggregated information
- Aggregated volume
- Price
600,000 Ordinary Shares at 3.249 pence per Ordinary Share
e)
Date of the transaction
9 August 2016
f)
Place of the transaction
London Stock Exchange, AIM
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHSSLFDUFMSEFA